CAS 865792-18-3

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone

Description:

The chemical substance known as "6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone" with the CAS number 865792-18-3 is a complex organic compound characterized by its unique structural features. It contains a quinolinone core, which is a bicyclic structure known for its diverse biological activities. The presence of cyclohexyl and tetrazole moieties suggests potential pharmacological properties, as tetrazoles are often associated with bioactive compounds. The butoxy and butyl substituents enhance its lipophilicity, potentially influencing its solubility and permeability in biological systems. This compound may exhibit interactions with various biological targets, making it of interest in medicinal chemistry and drug development. Its specific characteristics, such as melting point, solubility, and reactivity, would require empirical data for precise evaluation, but its structural complexity indicates potential for significant biological activity. Further studies would be necessary to elucidate its mechanism of action and therapeutic applications.

Formula: C₃₁H₄₅N₉O₂

Synonyms:

• 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butyl]-3,4-dihydro-1H-quinolin-2-one
• 6-(4(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-1-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl)-3,4-dihydroquinolin-2(1H)-one
• 1-(4-(5-Cyclohexyl-1H-Tetrazol-1-Yl)Butyl)-6-(4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy)-3,4-Dihydroquinolin-2(1H)-One

Cilostazol Related Compound C (1-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)

CAS: 865792-18-3

Lactams, nesoi

Formula: C₃₁H₄₅N₉O₂

Color and Shape: White Powder

Molecular weight: 575.36962

Ref: 45-1134186

1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one

Controlled Product

CAS: 865792-18-3

Formula: C₃₁H₄₅N₉O₂

Color and Shape: Neat

Molecular weight: 575.75

Ref: 86-MM0796.03

Cilostazol USP Related Compound C

CAS: 865792-18-3

Formula: C₃₁H₄₅N₉O₂

Molecular weight: 575.76

Ref: 4Z-C-079

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone

Controlled Product

CAS: 865792-18-3

Impurity Cilostazol USP Related Compound C
Applications 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone, is an impurity of Cilostazol (C441500), a potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake.
References Suri, A., et al.: J. Clin. Pharmacol., 38, 144 (1998), Park, S.-W., et al.: Am. J. Cardiol., 84, 511 (1999), Tsuchikane, E., et al.: Circulation, 100, 21 (1999);

Formula: C₃₁H₄₅N₉O₂

Color and Shape: Neat

Molecular weight: 575.75

Ref: TR-C988255

Cilostazol Related Compound C

CAS: 865792-18-3

Cilostazol is a drug that is used to treat the symptoms of intermittent claudication. It is a quinone-type inorganic base, obtained by the hydration of cilostazol. Cilostazol is an inhibitor of phosphodiesterase type 3 (PDE3) and has been shown to inhibit platelet aggregation, which may be due to its ability to inhibit PDE3 and prevent the breakdown of cyclic guanosine monophosphate (cGMP).

Formula: C₃₁H₄₅N₉O₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 575.75 g/mol

Ref: 3D-QJB79218

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone-d11

Controlled Product

CAS: 865792-18-3

Formula: C₃₁D₁₁H₃₄N₉O₂

Color and Shape: Neat

Molecular weight: 586.816

Ref: TR-C988257

Cilostazol USP Related Compound C

CAS: 865792-18-3

Formula: C₃₁H₄₅N₉O₂

Molecular weight: 575.75

Ref: ST-EA-CP-C6003